Repositorio Dspace

Listar por tema "Immune Checkpoint Inhibitors"

Listar por tema "Immune Checkpoint Inhibitors"

Ordenar por:Orden:Resultados:

  • Sánchez-Cánovas, Manuel; Fernández-Garay, David; Adoamnei, Evdochia; Guirao-García, Esperanza; López-Robles, Javier; Cacho-Lavín, Diego; Martínez-de-Castro, Eva; Campos-Balea, Begoña; Garrido-Fernández, Alberto; Fernández-Pérez, Isaura; Ferrandez-Arias, Asia; Suárez, Noelia; Quintanar-Verdúguez, Teresa; Lobo-de-Mena, Miriam; Rodríguez, Laura; Gutiérrez, David; Martín-Fernández-de-Soignie, Ana-Manuela; García-Adrian, Silvia; Ferrer-Pérez, Ana-Isabel; Delgado-Heredia, María-Jesús; Muñoz-Lerma, Amelia; Luque, Raquel; Mazariegos-Rubi, Manuel; Belén-Rupérez-Blanco, Ana; García-Escobar, Ignacio; Mendiola, Jaime; Muñoz-Martín, Andrés-Jesús (Springer Int Publ Ag, 2023-10)
    PURPOSE: Both venous and arterial thrombotic events (VTE/AT) can be associated with immune checkpoint inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. METHODS/PATIENTS: ...
  • Sánchez-Cánovas, Manuel; Fernández-Garay, David; Ortega-Morán, Laura; Rubio-Pérez, Jaime; Guirao-Rubio, Carlos-Miguel; Lobo-de-Mena, Miriam; Obispo-Portero, Berta; Brenes-Castro, Jesús; Lage, Yolanda; Cacho-Lavín, Diego; Rupérez-Blanco, Ana-Belén; Martín-Fernández-de-Soignie, Ana-Manuela; Benoit-Perejon, Jonatan-Zacarias; Jiménez-Colomo, Laura; Blaya-Boluda, Noel; Bosque-Moreno, Javier; Quintanar-Verdúguez, Teresa; Rosa-Garrido, Carmen; Martín-Huertas, Roberto; Puig, Carme; Muñoz-Martín, Andrés-Jesús (Springer Int Publ Ag, 2022-10)
    PURPOSE: Immune Checkpoint Inhibitors (ICI) can be associated with thrombotic events, both venous and arterial (VTE/AT). However, there is a paucity of information regarding patients in routine clinical practice. ...
  • Díaz-Carrasco, María-Sacramento; González-Haba, Eva; García-Soler, Juana-Inés; Espuny-Miró, Alberto (ELSEVIER, 2020-07-01)
    OBJECTIVE: The present paper provides a literature review aimed at  identifying the tumor-dependent factors capable of influencing a  subject's response to immune checkpoint inhibitors, with a special  emphasis on those that ...